Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases
Purpose: to evaluate the effect of a new antiallergic drug epinastine in the treatment of seasonal conjunctivitis as manifested in clinical cases.Materials and methods. 37 people (22 men and 15 women) were observed during spring exacerbation of the allergic conjunctivitis, from mid-March to the end...
Saved in:
| Main Author: | E. V. Yani |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2023-12-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/1368 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Results of Observational Study and Integration of Epinastine 0,05% in Treatment Algorythms of Patients with Seasonal Allergic Conjunctivitis
by: D. Yu. Maychuk, et al.
Published: (2024-06-01) -
Allergic Conjunctivitis
by: Muhammed Vally, et al.
Published: (2017-11-01) -
Topical treatment options for allergic conjunctivitis
by: Sumari Davis
Published: (2015-07-01) -
Evaluation of the Therapeutic Effectiveness of Combined Action Antiallergic Drugs in Monotherapy of Allergic Conjunctivitis
by: N. G. Zumbulidze, et al.
Published: (2020-04-01) -
Evaluation on the clinical findings and allergological factors of local allergic conjunctivitis and non-local allergic conjunctivitis
by: Yasuo Yamana, et al.
Published: (2025-04-01)